KUALA LUMPUR, Malaysia,May 2, 2025/PRNewswire/ -- AsSoutheast Asia'spharmaceutical industry rapidly evolves—driven by regulatory harmonization, innovation, and growing healthcare demand—CPHI South East Asia 2025 provides a vital platform to connect with regional stakeholders, showcase breakthroughs, and unlock business opportunities across the ASEAN region.
Taking place for the first time inKuala Lumpur, Malaysia, from 16–18 July 2025, the event will bring together 8,000+ professionals, 400+ global exhibitors, and curated buyers from acrossAsiaand beyond—positioning it as the region's most impactful pharma event.
Unlock Growth Across ASEAN's Pharma Markets
FromIndonesia,Thailand,Vietnam,the PhilippinestoMalaysia,Southeast Asiais one of the world's most dynamic pharmaceutical regions. Governments are investing in local manufacturing, reforming regulatory systems, and opening doors to international partnerships.
Malaysia, as this year's host, plays a central role in this growth.[1]The country's pharmaceutical market is expected to rise fromRM11.2 billionin 2022 toRM15.5 billionby 2027, supported by the New Industrial Master Plan (NIMP) 2030, which incentivizes the production of APIs, biologics, and vaccines.
[2]Strategically located betweenSingaporeandIndonesia,Malaysiaoffers streamlined access to regional distributors, CDMOs, and packaging partners—makingKuala Lumpura strategic gateway to ASEAN-wide expansion.
Source: 1. MIDA, MITI Malaysia |
2. ASEAN Pharmaceutical Industry Report |
At CPHI South East Asia 2025, you'll be able to:
Event Highlights
Venue: MITEC,Kuala Lumpur
Dates: 16–18 July 2025
Explore more at: https://www.cphi.com/sea
Register to visit at: https://cphisea.imasia-passport.com/
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cphi-south-east-asia-2025-your-gateway-to-aseans-expanding-pharmaceutical-landscape-302444987.html
SOURCE CPHI South East Asia